Jump to Navigation

Free Articles > Free Article

OTC Agents for Depression, Anxiety, and Insomnia [Free Article]

Natural and Alternative Treatments in Psychiatry, The Carlat Psychiatry Report

More than 38% of Americans use complementary and alternative medicine (CAM) yearly, with 12.7% using so-called “natural products." More than a third of people over age 50 report use of supplements, yet only about half have discussed this with their doctors.

The Psychosis Prodrome [Free Article]

The Carlat Psychiatry Report - TCPR - January 2013

At the crossroads of these experiences lies the concept of the psychosis prodrome and early intervention/prevention efforts. But without evidence of a florid psychotic episode, when should one intervene?

Dialectical Behavior Therapy: A Primer [Free Article]

Marsha Linehan developed DBT to help patients with BPD (Linehan MM, Cognitive Behavioral Treatment of Borderline Personality Disorder. New York, NY: The Guilford Press;1993), and over the past two decades it has received strong empirical support.

Deplin: Is it Just Folate by Another Name? [Free Article]

Deplin: Is it Just Folate by Another Name? - The Carlat Psychiatry Report

Patients are probably asking you about Deplin, or L-methylfolate, a version of folic acid that is being marketed by Pamlab as an adjunctive treatment for depression.

Which Electronic Health Record Should You Buy? A Review of Three Products

The Carlat Report - Electronic Medical Records

There are a lot of electronic health record (EHR—also called electronic medical record, or EMR) companies vying for your hard earned cash. How do you decide among them?

Four “New” Antidepressants. Or Are They? [Free Article]

What’s new in antidepressant treatment? Not much.

Latuda: “Procognitive” or Pro-Profit? [Free Article]

Source: 
Schizophrenia

Lurasidone (Latuda) was approved by the FDA for schizophrenia in October 2010 and is the 10th atypical antipsychotic in our toolbox. The key question is: does lurasidone have any advantages over existing agents, or is it just another “me-too” drug?

The DSM-5: A Guide to Coming Changes [Free Article]

Sometime in 2013, we’ll presumably be forced to shell out a hundred bucks or so for the fifth edition of DSM. While we do not have the space to review every potential change here, we will cover those of most clinical importance. Free Article!

Drug Interactions in Psychiatry: A Practical Review [Free Article]

In this article we’ll survey those drug interactions that are most likely to become troublesome in day to day psychiatric practice.

How Do Psychotherapy and Medication Change the Brain? [Free Article]

We know that for many conditions, both medications and psychotherapy work about equally well. Common sense would dictate that there is some final common pathway of neuropsychiatric change underlying the symptomatic improvements we see. But identifying what is happening in a living human brain is extremely tricky.

Treating Anxiety in Alcoholics

Source: 
Alcoholism

Alcoholism and anxiety go hand in hand. The extent of this comorbidity is clear from the numbers: as many as 45% of patients with alcohol disorders meet diagnostic criteria for a co-occurring anxiety disorder.

Benzodiazepines: A Guide to Safe Prescribing

Source: 
Anxiety Disorders
The Carlat Report - Anxiety Disorders

Most of us who prescribe benzodiazepines (BZs) have a love-hate relationship with them. On the one hand, they work quickly and effectively for anxiety and agitation, but on the other hand, we worry about sedative side effects and the fact that they can be difficult to taper because of withdrawal symptoms.

A Primer on Drug Testing

Source: 
Substance Abuse

If you are a typical psychiatrist practicing in a setting other than a substance abuse clinic, chances are good that you rarely order drug testing on most of your patients. But should you be doing this more?